期刊文献+

血浆同型半胱氨酸与老年2型糖尿病血管并发症关系

Relationship between plasma homocysteine and vascular complications in elderly type 2 diabetics
下载PDF
导出
摘要 目的探讨老年2型糖尿病血浆同型半胱氨酸(Hcy)水平与大血管、微血管并发症之间的关系,同时了解血浆Hcy与叶酸、维生素(Vit)B_(12)、超敏C反应蛋白(s-CRP)、纤维蛋白原(Fg)之间的关系。方法测定227例老年2型糖尿病患者血浆Hcy、空腹血糖(FPG)、餐后血糖(2hPG)、糖化血红蛋白(HbA_1c)、空腹胰岛素(FINS)、C肽、胆同醇(Tc)、三酰甘油(TG)、高密度脂蛋白(HDL-C)、低密度脂蛋白(LDL-C)、尿微量白蛋白/肌酐比值(Alb/ Cr)、叶酸、VitB_(12)、hs-CRP和纤维蛋白原(Fg),采用B超测量大动脉内膜中层厚度(IMT)并进行眼底视网膜检查。结果①血浆Hcy≥12μmol/L组的脉压差、体重指数(BMI)、HbA_1c、TC、TG、尿Alb/Cr、hs-CRP、Fg及颈总动脉、股总动脉、腘动脉IMT、视网膜病变比例、尿Alb/Cr均显著高于血浆<12μmol/L组(P<0.05~0.01);叶酸、VitB_(12)显著降低(P值均<0.01)。Hcy与2hPG(β=0.380)、TG(β=0.384)、脉压差(β=0.177)、s-CRP(β= 0.455)、Fg(β=0.609)、颈总动脉IMT(β=0.214)、股总动脉IMT(β=0.362)、腘动脉IMT(β=0.382)、视网膜病变(β=0.361)呈显著正相关(P<0.05);与叶酸(β=-0.242)、VitB_(12)(β=-0.253)呈显著负相关(P<0.05)。②大动脉内膜中层增厚(IMT≥1.2 mm)、蛋白尿组(Alb/Cr≥2.25mg/mmol)的血浆Hcy值均明显增高(P值均<0.01)。结论血浆Hcy值≥12μmol/L时,老年2型糖尿病患者的大血管及微血管病变发生的危险性明显增加。血浆Hcy值随大动脉IMT的增加和尿Alb/Cr的增高而增高。Hcy与hs-CRP、Fg等炎症因子可能共同参与了老年2型糖尿病大血管和微血管并发症的发展。 objective To appraise the relationship between plasma homocysteine(Hcy) level and macro-, microvascular complications in type 2 diabetic elderly and the relevance of plasma homocysteine(Hcy) and folic acid, Vitamin B12 (VitB12), highly sensitive C-reactive protein(hs-CRP) and fibrinogen(Fg). Methods Two hundred and twenty-seven elderly subjects with type 2 diabetes were undertaken detection of plasma Hey, fasting plasma glucose, post prandial glucose(PPG), hemoglobin A1c (HbA1c), fasting insulin(FINS), C-peptide, total cholesterol ( TC), triglyceride ( TG), high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C), folic acid, VitB12, hs-CRP, Fg, microalbuminuria/creatinine ratio(Alb/Cr); and the arterial intimamedial thickness(IMT) was measured by B ultrasound and fundoscopy. Results ①Pulse pressure, BMI, HbA1c, TC, TG, urine Alb/Cr, folic acid, VitB12, hs-CRP and Fg in the group with plasma Hcy =12μmol/L were significantly higher than those in the group with plasma Hey level 〈12 μmol/L(P 〈 0.05 - 0.01), while the levels of folate and VitaminB12 of the former were lower than those of the latter(P 〈 0.01). Not only the IMT of carotid, femoral and popliteal arteries varied between the two groups(P 〈 0.01), but also the retinopathy and microalbuminuria/creatinine ratio(Alb/Cr) were significantly different(P 〈0. 01). Multiple regression analysis showed that the plasma Hey level was positively correlated with PPG, TG, pulse pressure, hs-CRP, Fg, IMT of carotid, femoral and popliteal arteries and retinopathy found(P 〈 0.05) but negatively correlated with folic acidand VitB12 (P 〈 0.05).②A higher Hcy level was observed in those with a thicker arterial intima-medial layer(P 〈 0.01). ③Hcy value in the group of elevated urine Alb/Cr increased significantly(P 〈 0.01). Conclusions ①The risk of developing macro-and microvascular complications rises predominantly in those with plasma Hcy level higher than 12 μmol/L in the elderly diabetics. ②Elevated plasma Hcy level shows consistency with increase of IMT and urine Alb/Cr. ③Negative correlation existed in folic acid and VitB12 versus plasma Hcy level. ④Plasma Hcy and the inflammatory factors, like hs-CRP and Fg, may all contribute to the progression of macro-and microvascular complications in the elderly diabetics.
出处 《上海医学》 CAS CSCD 北大核心 2006年第7期435-438,共4页 Shanghai Medical Journal
关键词 老年2型糖尿病 血管病变 血浆同型半胱氨酸 炎症因子 叶酸 Elderly type 2 diabetics Vascular complications Plasma homocysteine Inflammatory factors Folic acid
  • 相关文献

参考文献12

  • 1Aronow WS.Homocysteine.The association with atherosclerotic vascular disease in older persons.Geriatrics,2003,58:22-28.
  • 2Darius H,Pittrow D,Haberl R,et al.Are elevated homocysteine plasma levels related to peripheral arterial disease? Results from a cross-sectional study of 6880 primary care patients.Eur J Clin Invest,2003,33:751-757.
  • 3Vermeer SE,Den Heijer T,Koudstaal PJ,et al.Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study.Stroke,2003,34:392-396.
  • 4Drzewoski J,Czupryniak L,Chwatko G,et al.Hyperhomocysteinemia in poorly controlled type 2 diabetes patients.Diabetes Nutr Metab,2000,13:319-324.
  • 5O'Leary DH,Polak JF,Kronmal RA,et al.Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults,Cardiovascular Health Study Collaborative Research Group.New Engl J Med,1999,340:14-22.
  • 6Neugebauer S,Baba T,Kurokawa K,et al.Defective homocysteine metabolism as a risk factor for diabetic retinopathy.Lancet,1997,349:473-474.
  • 7杨国庆,陆菊明,潘长玉.血浆同型半胱氨酸浓度与2型糖尿病视网膜病变的关系[J].中华内科杂志,2002,41(1):34-38. 被引量:62
  • 8Bloomgarden ZT.Inflammation and insulin resistance.Diabetes Care,2003,26:1619-1623.
  • 9Vermeulen EG,Stehouwer CD,Twisk JW,et al.Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis:a randomised,placebo-controlled trial.Lancet,2000,355:517-522.
  • 10Quinlivan EP,McPartlin J,McNulty H,et al.Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease.Lancet,2002,359:227-228.

二级参考文献10

  • 1Fonseca VA, Mudaliar S, Schmidt B ,et al. Plasma homocysteine concentration are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects. Metabolism, 1998,47:686-689.
  • 2Wollesen F, Brattstrom L, Refsum H, et al. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int, 1999, 55:1028-1035.
  • 3Vaccaro O, Ingrosso D, Rivellese A, et al. Moderate hyper-homocysteinaemia and retinopathy in insulin-dependent diabetes. Lancet,1997,349:1102-1103.
  • 4Tsai JC, Wang H, Perrella MA, et al. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest, 1996,97:146-152.
  • 50 Blom HJ, Kleinveld HA, Boers GH, et al. Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia. Eur J Clin Invest, 1995,25:149-154.
  • 6Montalescot G,Ankri A,Chadefaux-Vekemans B,et al. Plasmsa homocysteine and the extent of atherosclerosis in patients with coronary disease. Int J Cardiol, 1997,60:295-300.
  • 7Gilfix BM, Blank DW, Rosenblatt DS. Novel reductant for deter-mination of total plasma homocysteine. Clin Chem, 1997,43:687-688.
  • 8Hoogeveen EK, Kostense PJ, Beks PJ, et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arherioscler Thromb Vasc Biol, 1998,18:133-138.
  • 9van den Berg M, Stehouwer CD, Bierdrager E, et al. Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease. Arherioscler Thromb Vasc Biol, 1996,16:165-171.
  • 10Drzewoski J, Czupryniak L, Chwatko G, et al. Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents. Diabetes Care, 1999,22:2097-2099.

共引文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部